Inspire Medical Systems (INSP) Gross Profit (2017 - 2026)

Inspire Medical Systems has disclosed Gross Profit across 10 years of filings, most recently posting $176.9 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $176.9 million, up 3.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $785.1 million (up 10.39% YoY), and the FY2025 annual result was $778.8 million, up 14.55% from the prior year.
• Gross Profit came in at $176.9 million for Q1 2026 at Inspire Medical Systems, down from $233.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $233.0 million in Q4 2025 to a low of $59.4 million in Q1 2022.
• The 5-year median for Gross Profit is $164.5 million (2023), against an average of $147.4 million.
• Across the five-year window, Gross Profit surged 81.9% in 2023 and gained 3.7% in 2026, its largest moves.
• Inspire Medical Systems' Gross Profit stood at $115.7 million in 2022, then jumped by 42.08% to $164.5 million in 2023, then increased by 23.88% to $203.7 million in 2024, then gained by 14.37% to $233.0 million in 2025, then retreated by 24.07% to $176.9 million in 2026.
• The last three Gross Profit figures came in at $176.9 million (Q1 2026), $233.0 million (Q4 2025), and $192.7 million (Q3 2025), per Business Quant data.